Search research articles
Contact Us
Filters
Showing results (161-170 of 380) with videos related to
Page
of 38
Sort By:
Ebiomedicine
|
February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Alois Gratwohl, Anna Sureda, Helen Baldomero, et al.
Bone Marrow Transplantation
|
November 5, 2025
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT
Vanderson Rocha, Myriam Labopin, Anna Maria Raiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2016
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial
Patrice Carde, Matthias Karrasch, Catherine Fortpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma
Andreas Josting, Horst Müller, Peter Borchmann, et al.
Leukemia & Lymphoma
|
August 27, 2020
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy
David Straus, Graham Collins, Jan Walewski, et al.
Bone Marrow Transplantation
|
May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation
Mohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Cytotherapy
|
February 28, 2024
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients
Carlota Gudiol, Montserrat Arnan, Manuela Aguilar-Guisado, et al.
European Journal of Haematology
|
November 27, 2019
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions
Santiago Mercadal, Juan-Manuel Sancho, Fina Climent, et al.
European Journal of Haematology
|
March 24, 2007
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, et al.
Page
of 38
Search research articles
Search
Showing results (161-170 of 380) with videos related to
Sort By:
Page
of 38
Ebiomedicine
|
February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Alois Gratwohl, Anna Sureda, Helen Baldomero, et al.
Bone Marrow Transplantation
|
November 5, 2025
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT
Vanderson Rocha, Myriam Labopin, Anna Maria Raiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2016
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial
Patrice Carde, Matthias Karrasch, Catherine Fortpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma
Andreas Josting, Horst Müller, Peter Borchmann, et al.
Leukemia & Lymphoma
|
August 27, 2020
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy
David Straus, Graham Collins, Jan Walewski, et al.
Bone Marrow Transplantation
|
May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation
Mohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Cytotherapy
|
February 28, 2024
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients
Carlota Gudiol, Montserrat Arnan, Manuela Aguilar-Guisado, et al.
European Journal of Haematology
|
November 27, 2019
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions
Santiago Mercadal, Juan-Manuel Sancho, Fina Climent, et al.
European Journal of Haematology
|
March 24, 2007
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, et al.
Page
of 38